Received Jul 22, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
strokes; cardiac problems; COVID-19; COVID-19; This is a spontaneous report received from a Consumer or other non HCP. A patient (age and gender not provided) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CEREBROVASCULAR ACCIDENT (hospitalization, medically significant), outcome "recovering", described as "strokes"; CARDIAC DISORDER (hospitalization), outcome "unknown", described as "cardiac problems"; DRUG INEFFECTIVE (hospitalization, medically significant), COVID-19 (hospitalization, medically significant), outcome "unknown" and all described as "COVID-19". Clinical course: Patient was enrolled in a Pfizer clinical trial regarding a COVID-19 Vaccine which they've had a reaction to. Caller remained hospitalized for COVID-19 after the shot, experienced cardiac problems, and also currently recovering from strokes suffered while being hospitalized. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.